[James666666]

Hi. I’ve been reading the posts from you and Hayfarmer over the past few months. You’ve both made some insightful comments.

I’ve held this stock for a long time like you. Arun knows what he’s doing. He is patient and not promotional. He’s experienced and he’s built companies up and sold them before. The pandemic set PROF back and it was unfortunate to only recently get CPT 1 approval effective 2025 rather than a year earlier in 2024 if the application had been approved in 2022 rather than being withdrawn. In any event TULSA has huge potential to disrupt and become the standard of care. However, the company will almost certainly need to raise equity again as sales will not really pick up until 2025 even with c-code approval outside of hospitals. More debt as a bridge is an option but I think they will dilute again.

The stock is so thinly traded. I don’t pay much attention to the daily stock prices. If things work out - and I think there’s a good chance they do - the stock will be much much higher in a few years. The market opportunity is significant and if the company can even capture a small portion of that with a modest multiple the stock will be 4-5 times higher than it is today.

The best thing is very few people have even heard about PROF. So like all small caps there are risks but the risk reward for this one is very interesting imo.

[chocolate man]

I don't know what he mentioned in his downgrade, i was only able to see the headline. I just search for Raymond James new reports for Profound Medical.

[hayfarmer]

Yes they have 3 days. I agree it's strange to downgrade it now unless you're hoping to cause selling you can take advantage of and buy cheaper. Did the RJ downgrade mention the insurance C code? I don't have access to what RJ said in it's downgrade.

[chocolate man]

I hope I'm also wrong about having inside information. I believe a public company has 3 business days to release information that is material to the price of the stock. One of the catalysts he was writing about was the insurance code and was expecting the news to come out in July or early August. i believe we would have a substantial move to the upside if it was approved. Why come out with a downgrade before we find out if it's approved. PROF's numbers may be off but that's looking in a rear view mirrow if they get the approval. I still own a nice amount of stock and some options. I'm not sure you know this but RF sold a bunch of PROF stock in the 1st quarter. I will never forget about this stock, i've been in it for years.

[hayfarmer]

Totally guessing but I'm thinking volume is low because very few retail investors are in this stock and RJ has already sold what they want to sell. After done selling they downgraded and probably hope to buy back cheaper. If that is the plan today's action didn't really go their way. The downgrade didn't result in many sellers.s In fact I saw a lot of buying late in the day. I am also very frustrated with the ultra slow sales progress.

I hope you'/re not right on them knowing about the insurance. That would be insider information but I know it happens. Government often makes no sense but it seems like medicare would want this procedure since it keeps people out of the hospital. It must be cheaper for medicare vs some of the alternatives.

I don't know your plans but I suggest keeping a few shares so it's on your quote list in case things change so you don't forget about it.

[chocolate man]

I also find it interesting that the stock dropped 25% before he made his downgrade public! I'm not sure what the stock will do Monday, but aren't you a little surprised that the stock did not drop more and volume was relatively lite today.

[chocolate man]

They have the best mouse trap, but for whatever reason they apparently can't get their act together! I have to believe RJ knows they aren't getting insurance approval for January 2024, hence the downgrade today.

[hayfarmer]

It's already down a lot. If I sell any I'm waiting for the C code news.

[hayfarmer]

I just saw Raymond James downgraded PROF this morning and lowered target to 23 from 28. I see now a week ago a story RJ had reduced it's holdings also in the 1st qtr by 37%. This explains the weakness

[chocolate man]

RJ downgraded PROF this morning. I've been selling stock all day.

[hayfarmer]

Breaking well below 200 day moving avg now. Not good but down so many days in a row on no known news is very odd.

[chocolate man]

Thanks for the reply, I'm going to hang tight and wait for their earnings report.

[hayfarmer]

It is down 9 out of the last 10 days so must be getting really oversold. I keep waiting for the C code news but it hasn't happened. I just checked and last year they reported Aug 4 so that is going to be late too. I'm guessing the company is waiting for C code news to report the quarter.

Maybe sales are not great? I don't know what else could be wrong.

[chocolate man]

Something is not right with this stock!

[chocolate man]

I bought more stock today at $12.00.

[hayfarmer]

I am also on Investorvillage.com where you can PM me if you ever want to. There is also a PROF board there but I was the only one posting so I stopped using it.

[chocolate man]

I've been in and out of that stock many times over the last few years. I feel your pain and if they get approval you will make a lot of money.

[hayfarmer]

I've been in the CRMD I mentioned for years. They have a fantastic drug that will save many lives but so far the FDA has denied it twice for manufacturing reasons. They are on the third try now. Want to talk about frustrating?

[chocolate man]

I agree 100%, it just gets very frustrating at times.

[hayfarmer]

I agree with you, this is an unknown stock. At one time when I first invested a few years ago I read 80% was privately held. IMO, the low float and unknown combination will be explosive some day once the growth is big enough for everyone to notice. They have the best solution imo for most patients so it's just a matter of time and patience.

[chocolate man]

Thanks for the quick reply! Sometimes I feel like we are the only retail investors in this stock. I wonder why RJ isn't banging the table at this price. It could be because they are being cautious before the C code news.

[hayfarmer]

The only problem I see is how long it's taking for the growth. The C code news could be any day and that should help; assuming it's good news as I expect. Holding 12 would be nice. There seems to be a lot of support there. I'm not selling any.

[chocolate man]

Hayfarmer, do you think there is a problem with PROF?

[chocolate man]

I bought 100 shares this morning at $12.76. this was my fill.

3 ea @ 9.56.48am
3 ea @ 9.59.06am
94 ea @ 9.59.45am

[hayfarmer]

C code news coming soon. Maybe that will spark a rally

[chocolate man]

New report out from RJ. He reiterates his $20.00 price target. He expects them to receive approval for the expansion of the C-code for ASCs in JUly or August. He said revenue inflection will be pulled forward in YR24. We escalate our revenue estimate accordingly. He said the recent price drop in the stock which fell 15% in recent trading sessions have no basis in fundermentals

[chocolate man]

Hoping the seller is done!

[hayfarmer]

Another company I'm invested in is CRMD if you want to check it out. They have under FDA review a catheter lock solution that cuts catheter related infections by over 70%. They have gotten 2 CRL's for manufacturing issues so far so it's been frustrating but I think it has a lot of potential if they can ever get approval.

[chocolate man]

I ended up buying some stock just before the close. I think I made a good move, time will tell.

[chocolate man]

PRN on the Toronto exchage has only traded 23,000 shares as 3.15pm.

[chocolate man]

I want his to close above $15.00 today

[chocolate man]

I thought it was a buy order. The stock then ran $15.49. I would love to know what's going on.

[hayfarmer]

Over 42k shares traded in one block at 15. Appeared to be a sell order. I don't think it means much. It's had a decent run and no news expected until July now when a decision on the outpatient C code should be made.

[hayfarmer]

I agree with you Dr's should recommend it however many don't know about it and the financial motive is for the doctor to recommend a service he can provide. An ad campaign to inform patients would help but that is expensive.

When I first invested I think I read only 20% of shares were in the float which is something a liked. Not sure if it is the same now. The coimpany is still an unknown which is our advantage right now.

[chocolate man]

Raymond James has 8,400 financial advisors throughout USA, Canada and overseas. If only 5% would recommend PROF to their clients this would be a $20.00-$25.00 stock in no time.

[chocolate man]

Your post is very interesting, I would think that Raymond James is a big brokerage and they don't have any problems covering PROF. I wonder how much of a float is really out there for PROF? I wonder why the two of us are the only people conversing back and forth? I think we both know with the insurance coverage now approved we have a tremendous opportunity to make a lot of money with PROF. I wonder how many shares could be short in this company? I would love to see more insider buying! When word gets out about this company, i don't where people will get any weight ( shares ) to buy. They will have to pay up and the price will explode. If the docs aren't recommending Tulsa to their patients they are doing them a great disservice!!

[hayfarmer]

One of my brokers is with UBS and he can't buy this because it is not covered by CFRA Marketscope Advisor. I emailed Investor relations to let them know and asked them to look into how to get coverred. UBS is a big brokerage. I wonder if other big brokers can't buy it. That could be holding down the price.

He said he can't buy it in any managed account.

[chocolate man]

It would be great to get coverage from one of the big boys.

[chocolate man]

I won't be able to listen to the live webinar tonight. I hope someone can fill me in what was said during the call.

[chocolate man]

Thank you!

[hayfarmer]

Another target raise from 14 to 18

https://www.cantechletter.com/2023/06/profound-medical-wins-target-raise-with-leede-jones-gable/#

[chocolate man]

I read it in BioTuesdays. I know this is the real deal! There is so little stock floating around, when a big guy wants in he will have to buy it in small lots. Tomorrow and Wednesday should be very interesting. This company is still so unknown that when the retail buyers find out about it we will be the 20's in no time.

[hayfarmer]

Thanks for posting. Do you have any links to reports?

My impression of this CEO is he may be interested in a buyout at some point. I read somewhere on this board or somewhere that is what he did with the last company he ran. But I think it's too early for him to sell it.

This stock is the real deal imo. I hope Lazerking still in and is ok. This company still mostly unknown. The broker who manages my IRA can't even buy it at UBS because not enough analyst coverage. I'm willing to wait 2 or 3 years when I think it could easily bring a buyout in 3 figures, meaning north of 100.

I may sell some shares on rips and try to buy back but I have a core position I won't be selling unless something fundamentally changes.

[chocolate man]

Research Capital raised it's price target to $17.25 from $10.90. Dr Uddin said with the CPT code essentially in hand he said Profound could now be acquired,

[chocolate man]

RJ raised their price target for PROF to $20.00.